Quick Links: Skip to main page content
Skip to Search
Skip to Topics Menu
Skip to Common Links
U.S. Food & Drug Administration
Follow FDA
En Español
Search FDA
Home
Food
Drugs
Medical Devices
Radiation-Emitting Products
Vaccines, Blood & Biologics
Animal & Veterinary
Cosmetics
Tobacco Products
Pediatric Studies Characteristics - Detail
FDA Home
Pediatrics
Pediatric Studies Characteristics
Detail
-
Please note:
JavaScript must be enabled for this application to work properly.
Check your settings
if you are unsure if your JavaScript is enabled.
Approval Date:
03/26/2012
Trade Name:
Singulair Oral Granules, Tablets, and Chewable Tablets
Generic or Proper Name (*):
montelukast
Indications Studied:
Prevention of exercise-induced bronchoconstriction
Therapeutic Category:
Antiasthmatic
Ages Studied:
6-14 years
Study #:
1
Study Type:
Efficacy/Safety/Tolerability
Study Design:
Blind/Placebo
No Patients:
66
No Centers:
22
No Countries:
4
BPCA(B), PREA(P):
P
-
-